Transchem

Transchem Net Tangible Assets

The Net Tangible Assets of Transchem (500422.BO) as of Oct 20, 2026 is 835.77 M INR. In the previous year, Net Tangible Assets was 793.15 M INR — a change of 5.37% (higher).

Net Tangible Assets

835.77 MINR

YoY

5.37%

Last updated:

Net Tangible Assets of Transchem is 2026 835.77 M INR. Net Tangible Assets of Transchem was 2025 793.15 M INR. It decreases by 5.37% higher compared to the previous year.

The Transchem Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2019
379.77 M INR
Jan 1, 2020
367.65 M INR
Jan 1, 2021
629.42 M INR
Jan 1, 2022
663.00 M INR
Jan 1, 2023
658.42 M INR
Jan 1, 2024
756.46 M INR
Jan 1, 2025
793.15 M INR
Jan 1, 2026
835.77 M INR
The Transchem Net Tangible Assets history
YEARNet Tangible AssetsYoY
835.77 MINR+5.37%
793.15 MINR+4.85%
756.46 MINR+14.89%
658.42 MINR-0.69%
663.00 MINR+5.34%
629.42 MINR+71.20%
367.65 MINR-3.19%
379.77 MINR+3.18%
368.07 MINR-3.11%
379.89 MINR-0.60%
382.17 MINR-0.34%
383.48 MINR+0.31%
382.29 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

Net Tangible Assets of Transchem is 835.77 M INR in 2026.

Net Tangible Assets of Transchem changed from 793.15 M INR to 835.77 M INR, representing a 5.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Transchem since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Transchem historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Transchem

All Key Metrics — Transchem